Headline
The latest stories from AHA Today.
Leaders from WakeMed Health and Hospitals in Raleigh, N.C., share strategies to overcome behavioral health disparities and increase patients’ access to appropriate caregivers at the right time and place.
Lesbian, gay and bisexual persons in the U.S. have higher self-reported prevalence of several underlying health conditions associated with severe COVID-19 outcomes, compared to heterosexual persons, according to a Centers for Disease Control and Prevention study.
The Food and Drug Administration revised and reissued its emergency use authorization for COVID-19 convalescent plasma to treat hospitalized patients with COVID-19.
Each year, the AHA Dick Davidson NOVA Award program recognizes health care’s bright stars who are working to improve community health through collaborations with other stakeholders.
The Health Information Sharing and Analysis Center and AHA will host a Feb. 10 panel discussion on best practices to combat unlawful robocalls to hospitals.
The U.S. health care system saves an estimated $122 billion annually by automating administrative transactions but could save $16.3 billion more by transitioning to fully electronic transactions, according to the latest annual CAQH Index.
Hospitals and health systems lost 2,100 jobs in January, as U.S. jobs overall increased by 49,000, according to data released by the Bureau of Labor Statistics.
Between March 22 and Oct. 17, 2020, weekly COVID-19-associated hospitalization rates reported by 10 COVID-19-Associated Hospitalization Surveillance Network sites declined by 5.5 percentage points for adults under age 65 after states began mandating the use of facemasks, according to a report …
The House and Senate passed a concurrent budget resolution giving Congress the option to use fast-track procedures to pass the president’s $1.9 trillion COVID-19 relief package with a simple majority in the Senate.
The Food and Drug Administration cautioned health care providers against using compounded remdesivir drug products due to the potential for patient exposure to substandard or adulterated products.